OverviewSuggest Edit
Natus Medical is a leading manufacturer of medical devices and software and a service provider for the Newborn Care, Neurology, Sleep, Hearing and Balance markets. Natus products are used in hospitals, clinics and laboratories worldwide. The Company's mission is to improve outcomes and patient care in target markets through innovative screening, diagnostic and treatment solutions.
| Type | Public | |
| Founded | 1989 | |
| HQ | Pleasanton, US | Map |
| Website | natus.com | |
| Employee Ratings | More |
Recent NewsAll News
- NATUS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Natus Medical Incorporated To Contact The Firm
- Global Hearing Healthcare Devices Market 2019-2025 Enhancement with Latest Technology & Growth by Key Players: William Demant, Sonova, GN Store Nord, Sivantos Group, Widex, Starkey, Cochlear, MED-EL GmbH, Natus Medical
- Natus Medical Announces Fourth Quarter and Full Year 2018 Financial Results
- Natus Medical Announces Continued Board Refreshment with Two New Independent Directors
Key People/Management at Natus Medical
Jonathan A. Kennedy
President, Chief Executive Officer and Director
Drew Davies
Executive Vice President and Chief Financial Officer.
Austin F. Noll
Vice President and General Manager, Neurology
D. Christopher Chung
Vice President Medical Affairs, Quality and Regulatory
Carsten Buhl
President & CEO, Otometrics SBU
Leslie McDonnell
Vice President and General Manager, Newborn Care
Report incorrect company information
Natus Medical Office Locations
Natus Medical has offices in Pleasanton, Mundelein, Seattle, Hauppauge and in 9 other locations
Pleasanton, US (HQ)
6701 Koll Center Pkwy #120
Golden, US
720 Corporate Cir Suite A
Hauppauge, US
150 Motor Pkwy #106
Middleton, US
3150 N Pleasant View Rd
Mundelein, US
Bio Logic Plaza
San Carlos, US
1501 Industrial Rd
Report incorrect company information
Natus Medical Financials and Metrics
Natus Medical Revenue
Natus Medical's revenue was reported to be $530.89 m in FY, 2018
| USD | |
|---|---|
Revenue (FY, 2018) | 530.9m |
Gross profit (FY, 2018) | 312.9m |
Gross profit margin (FY, 2018), % | 58.9% |
Net income (FY, 2018) | (22.9m) |
EBIT (FY, 2018) | (24.6m) |
Market capitalization (18-Mar-2019) | 912.7m |
Closing stock price (18-Mar-2019) | 27.0 |
Cash (31-Dec-2018) | 56.4m |
EV | 960.8m |
Natus Medical's current market capitalization is $912.7 m.
Annual
Quarterly
| USD | Q3, 2013 | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 85.4m | 85.6m | 86.3m | 89.9m | 89.4m | 91.9m | 94.6m | 87.3m | 96.0m | 90.9m | 124.7m | 122.2m | 122.6m | 128.6m | 130.7m | 130.6m |
Cost of goods sold | 34.1m | 35.7m | 35.3m | 34.3m | 35.1m | 33.8m | 35.5m | 32.5m | 37.9m | 32.2m | 56.9m | 54.6m | 47.1m | 55.4m | 52.9m | 51.6m |
Gross profit | 51.3m | 49.9m | 51.0m | 55.5m | 54.3m | 58.1m | 59.1m | 54.9m | 58.1m | 58.7m | 67.7m | 67.6m | 75.5m | 73.2m | 77.8m | 79.1m |
Gross profit Margin, % | 60% | 58% | 59% | 62% | 61% | 63% | 62% | 63% | 61% | 65% | 54% | 55% | 62% | 57% | 60% | 61% |
Annual
Quarterly
| USD | Q3, 2013 | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash | 44.2m | 59.6m | 56.0m | 57.8m | 67.0m | 73.2m | 82.2m | 81.3m | 96.3m | 81.1m | 103.8m | 80.3m |
Inventories | 39.4m | 35.5m | 35.5m | 37.1m | 41.4m | 44.9m | 46.1m | 45.7m | 43.6m | 51.7m | 67.7m | 69.3m |
Current Assets | 182.6m | 198.3m | 189.9m | 193.3m | 218.2m | 228.4m | 247.5m | 228.3m | 245.9m | 266.0m | 316.5m | 287.0m |
PP&E | 24.4m | 21.5m | 21.1m | 19.3m | 18.2m | 18.4m | 18.0m | 17.6m | 17.2m | 18.1m | 20.9m | 20.9m |
Annual
Quarterly
| USD | Q3, 2013 | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | 13.7m | 6.3m | 14.0m | 21.8m | 8.6m | 18.4m | 29.4m | 8.5m | 19.1m | 32.4m | 348.0k | (4.7m) | (13.2m) | (3.1m) | (5.7m) | (11.3m) |
Depreciation and Amortization | 9.6m | 3.3m | 5.6m | 8.6m | 7.2m | 11.3m | 4.2m | 8.4m | 12.8m | 6.7m | 13.8m | 20.9m | 7.9m | 16.7m | 25.7m | |
Inventories | (1.4m) | 1.6m | 2.7m | (469.0k) | 41.4m | (4.9m) | (7.0m) | (903.0k) | 352.0k | (6.4m) | 4.6m | 6.1m | 6.8m | 2.9m | (2.5m) | (5.2m) |
Accounts Payable | (5.9m) | (2.7m) | (4.0m) | (2.6m) | 22.3m | (1.9m) | 3.2m | (3.8m) | (4.7m) | (6.1m) | (1.1m) | (796.0k) | (9.5m) | (622.0k) | (364.0k) | (3.8m) |
| USD | Y, 2018 |
|---|---|
EV/EBIT | -39.1 x |
EV/CFO | 29.1 x |
Financial Leverage | 1.6 x |
Report incorrect company information
Natus Medical Online and Social Media Presence
Report incorrect company information
Natus Medical News and Updates
February 27, 2019
NATUS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Natus Medical Incorporated To Contact The Firm
NEW YORK, Feb. 27, 2019 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Natus Medical Incorporated ("Natus" or the "Company") (NASDAQ: BABY). If you invested in Natus stock or options and would like to discuss your...
February 14, 2019
Global Hearing Healthcare Devices Market 2019-2025 Enhancement with Latest Technology & Growth by Key Players: William Demant, Sonova, GN Store Nord, Sivantos Group, Widex, Starkey, Cochlear, MED-EL GmbH, Natus Medical
Summary:“Hearing Healthcare Devices” are designed to improve hearing by making sound audible to a person with hearing loss. These devices also known as Hearing aids which are classified as medical devices in most countries, and regulated by the respective regulations. Posted via Industry Today. Foll…
February 13, 2019
Natus Medical Announces Fourth Quarter and Full Year 2018 Financial Results
PLEASANTON, Calif., Feb. 13, 2019 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: BABY) (the “Company” or “Natus”) today announced financial results for the three months and full year ended December 31, 2018.
February 13, 2019
Natus Medical Announces Continued Board Refreshment with Two New Independent Directors
PLEASANTON, Calif., Feb. 13, 2019 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: BABY) announced today a significant refreshment of its board of directors with the appointment of Alice D. Schroeder, former CEO and Chair of WebTuner Corporation and Thomas J. Sullivan, President and CEO of …
January 11, 2019
Multi parameter Patient Monitoring Equipment Market with key players: Nihon Kohden Corporation, Spacelabs Healthcare, Medtronic, and Natus Medical.
The Global Multi parameter Patient Monitoring Equipment Market Report includes a comprehensive analysis of the present market. The report starts with the basic Global Multi parameter Patient Monitoring Equipment Market overview and then goes into each and every detail. Posted via Industry Today. Fol…
December 19, 2018
The Worldwide Market for Intracranial Pressure Monitoring Devices (2019-2023): Leading Players are Integra LifeSciences, Medtronic, Natus Medical and RAUMEDIC
DUBLIN, Dec 19, 2018 /PRNewswire/ -- The "Global Intracranial Pressure Monitoring Devices Market 2019-2023" report has been added to ResearchAndMarkets.com's offering. The global intracranial pressure monitoring devices market is forecasted to grow at a CAGR of nearly 7% during the...
Report incorrect company information
Natus Medical Frequently Asked Questions
When was Natus Medical founded?
Natus Medical was founded in 1989.
Who are Natus Medical key executives?
Natus Medical's key executives are Jonathan A. Kennedy, Drew Davies and Austin F. Noll.
How many employees does Natus Medical have?
Natus Medical has 1,160 employees.
What is Natus Medical revenue?
Latest Natus Medical annual revenue is $530.9 m.
What is Natus Medical revenue per employee?
Latest Natus Medical revenue per employee is $457.7 k.
Who are Natus Medical competitors?
Competitors of Natus Medical include Mauna Kea Technologies, Sight Sciences and Biovotion.
Where is Natus Medical headquarters?
Natus Medical headquarters is located at 6701 Koll Center Pkwy #120, Pleasanton.
Where are Natus Medical offices?
Natus Medical has offices in Pleasanton, Mundelein, Seattle, Hauppauge and in 9 other locations.
How many offices does Natus Medical have?
Natus Medical has 13 offices.